Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | -7.14% | +11.83% | -2.80% |
May. 14 | Transcript : MiNK Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | MiNK Therapeutics, Inc. announced that it has received $5.8 million in funding | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.80% | 38.87M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- INKT Stock
- News MiNK Therapeutics, Inc.
- Evercore ISI Starts MiNK Therapeutics at Outperform With $30 Price Target